← FDA Drug Approvals (Drugs@FDA)
RIZATRIPTAN BENZOATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2013-07-01
Drug application
- FDA Application #
ANDA202477- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIZATRIPTAN BENZOATE
- Generic name
- Rizatriptan Benzoate
- Active ingredients
- RIZATRIPTAN BENZOATE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- APOTEX INC
- First approval
- 2013-07-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown